144 related articles for article (PubMed ID: 22589393)
1. Serum sex steroids depict a nonlinear u-shaped association with high-risk prostate cancer at radical prostatectomy.
Salonia A; Abdollah F; Capitanio U; Suardi N; Briganti A; Gallina A; Colombo R; Ferrari M; Castagna G; Rigatti P; Montorsi F
Clin Cancer Res; 2012 Jul; 18(13):3648-57. PubMed ID: 22589393
[TBL] [Abstract][Full Text] [Related]
2. Circulating estradiol, but not testosterone, is a significant predictor of high-grade prostate cancer in patients undergoing radical prostatectomy.
Salonia A; Gallina A; Briganti A; Suardi N; Capitanio U; Abdollah F; Bertini R; Freschi M; Rigatti P; Montorsi F
Cancer; 2011 Nov; 117(22):5029-38. PubMed ID: 21495024
[TBL] [Abstract][Full Text] [Related]
3. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
Salonia A; Gallina A; Briganti A; Zanni G; Suardi N; Capitanio U; Colombo R; Bertini R; Freschi M; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2011 Apr; 107(8):1243-9. PubMed ID: 20883480
[TBL] [Abstract][Full Text] [Related]
4. Investigative clinical study on prostate cancer part IX and X: estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy.
Porcaro AB; Ghimenton C; Petrozziello A; Sava T; Migliorini F; Romano M; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C
Anticancer Res; 2012 Oct; 32(10):4523-32. PubMed ID: 23060581
[TBL] [Abstract][Full Text] [Related]
5. Preoperative hypogonadism is not an independent predictor of high-risk disease in patients undergoing radical prostatectomy.
Salonia A; Gallina A; Briganti A; Abdollah F; Suardi N; Capitanio U; Colombo R; Freschi M; Rigatti P; Montorsi F
Cancer; 2011 Sep; 117(17):3953-62. PubMed ID: 21365624
[TBL] [Abstract][Full Text] [Related]
6. Preoperative circulating sex hormones are not predictors of positive surgical margins at open radical prostatectomy.
Salonia A; Gallina A; Abdollah F; Briganti A; Capitanio U; Suardi N; Ferrari M; Raber M; Colombo R; Freschi M; Rigatti P; Montorsi F
World J Urol; 2012 Aug; 30(4):533-9. PubMed ID: 21935733
[TBL] [Abstract][Full Text] [Related]
7. Absence of relationship between steroid hormone levels and prostate cancer tumor grade.
Sher DJ; Mantzoros C; Jacobus S; Regan MM; Lee GS; Oh WK
Urology; 2009 Feb; 73(2):356-61; discussion 361-2. PubMed ID: 19036418
[TBL] [Abstract][Full Text] [Related]
8. Sex hormone-binding globulin is an independent predictor of biochemical recurrence after radical prostatectomy.
Waldert M; Schatzl G; Swietek N; Rom M; Klatte T
J Urol; 2012 Sep; 188(3):792-7. PubMed ID: 22818139
[TBL] [Abstract][Full Text] [Related]
9. Along the pituitary-testis-prostate axis, serum total testosterone is a significant preoperative variable independently contributing to separating the prostate cancer population into prostatectomy Gleason score groups.
Porcaro AB; Petrozziello A; Ghimenton C; Migliorini F; Sava T; Caruso B; Cocco C; Romano M; Artibani W
Anticancer Res; 2012 Nov; 32(11):5015-22. PubMed ID: 23155273
[TBL] [Abstract][Full Text] [Related]
10. Testosterone Levels Correlate With Grade Group 5 Prostate Cancer: Another Step Toward Personalized Medicine.
Capogrosso P; Ventimiglia E; Moschini M; Boeri L; Farina E; Finocchio N; Gandaglia G; Fossati N; Briganti A; Montorsi F; Salonia A
Prostate; 2017 Feb; 77(2):234-241. PubMed ID: 27775173
[TBL] [Abstract][Full Text] [Related]
11. Serum total testosterone is a significant preoperative variable independently contributing to separating the prostate cancer population into prostatectomy Gleason score groups.
Porcaro AB; Petrozziello A; Ghimenton C; Migliorini F; Sava T; Caruso B; Cocco C; Romano M; Cavalleri S; Artibani W
Urol Int; 2013; 91(1):55-61. PubMed ID: 23751412
[TBL] [Abstract][Full Text] [Related]
12. Influence of radical prostatectomy on serum hormone levels.
Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
[TBL] [Abstract][Full Text] [Related]
13. Preoperative sex steroids are significant predictors of early biochemical recurrence after radical prostatectomy.
Salonia A; Abdollah F; Capitanio U; Gallina A; Suardi N; Briganti A; Zanni G; Ferrari M; Castiglione F; Clementi MC; Rigatti P; Montorsi F
World J Urol; 2013 Apr; 31(2):275-80. PubMed ID: 22441310
[TBL] [Abstract][Full Text] [Related]
14. Sex hormone-binding globulin: a novel marker for nodal metastases prediction in prostate cancer patients undergoing extended pelvic lymph node dissection.
Salonia A; Briganti A; Gallina A; Karakiewicz P; Shariat S; Freschi M; Zanni G; Capitanio U; Bosi E; Rigatti P; Montorsi F
Urology; 2009 Apr; 73(4):850-5. PubMed ID: 19038425
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum sex hormone-binding globulin as a predictive marker for extraprostatic extension of tumor in patients with clinically localized prostate cancer.
Lee SE; Chung JS; Han BK; Park CS; Moon KH; Byun SS; Choe G; Hong SK
Eur Urol; 2008 Dec; 54(6):1324-32. PubMed ID: 18339472
[TBL] [Abstract][Full Text] [Related]
16. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC;
J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
[TBL] [Abstract][Full Text] [Related]
17. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Serum Sex Hormone-Binding Globulin Level Is an Independent Predictor of Biochemical Outcome After Radical Prostatectomy.
Lee JK; Byun SS; Lee SE; Hong SK
Medicine (Baltimore); 2015 Jul; 94(28):e1185. PubMed ID: 26181566
[TBL] [Abstract][Full Text] [Related]
19. Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer.
Schnoeller T; Jentzmik F; Rinnab L; Cronauer MV; Damjanoski I; Zengerling F; Ghazal AA; Schrader M; Schrader AJ
World J Urol; 2013 Apr; 31(2):253-9. PubMed ID: 22763628
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy.
Massengill JC; Sun L; Moul JW; Wu H; McLeod DG; Amling C; Lance R; Foley J; Sexton W; Kusuda L; Chung A; Soderdahl D; Donahue T
J Urol; 2003 May; 169(5):1670-5. PubMed ID: 12686805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
